- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Covid-19 vaccine (recombinant, adjuvanted) is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- J07BN04 Covid-19 vaccine (recombinant, adjuvanted) · COVID-19 vaccine
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Biologic
- Yes
All presentations
No presentations of Covid-19 vaccine (recombinant, adjuvanted) are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Covid-19 vaccine (recombinant, adjuvanted) available for export from India?
No presentation of Covid-19 vaccine (recombinant, adjuvanted) is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Covid-19 vaccine (recombinant, adjuvanted) authorised in the European Union?
Yes. Covid-19 vaccine (recombinant, adjuvanted) has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Covid-19 vaccine (recombinant, adjuvanted) need cold chain shipping?
No listed presentation of Covid-19 vaccine (recombinant, adjuvanted) is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Covid-19 vaccine (recombinant, adjuvanted) in?
Covid-19 vaccine (recombinant, adjuvanted) is classified under ATC code J07BN04 (Covid-19 vaccine (recombinant, adjuvanted)).
References
- Bimervax: European public assessment report (EPAR). European Medicines Agency. Retrieved 20 October 2026
- Nuvaxovid: European public assessment report (EPAR). European Medicines Agency. Retrieved 10 August 2026
Request Covid-19 vaccine (recombinant, adjuvanted) for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.